$70.00
Qulipta® (Atogepant) 60 mg Tablets – Bottle of 30 Tablets
Product Description:
Qulipta® is a prescription medication that contains atogepant, a CGRP receptor antagonist, used for the preventive treatment of chronic migraine in adults. Atogepant works by blocking the calcitonin gene-related peptide (CGRP) receptor, which plays a key role in the migraine process. By inhibiting CGRP, Qulipta helps reduce the frequency of migraine attacks and improve overall migraine control, providing relief from the debilitating symptoms of chronic migraines, including headache pain, nausea, and sensitivity to light and sound. Qulipta offers a convenient oral treatment option for patients who suffer from frequent migraines and need a preventive solution.
Product Features:
Active Ingredient: Atogepant
Strength: 60 mg per tablet
Dosage Form: Oral tablet
Quantity: Bottle of 30 tablets
Administration: Take one tablet once daily with or without food
Indications:
Preventive treatment of chronic migraine in adults
Reduces the frequency of migraine attacks by targeting the CGRP receptor
Effective in preventing migraines in patients who experience 15 or more headache days per month, with at least 8 of those days being migraine days
Not intended for the acute treatment of migraine attacks
Reviews
There are no reviews yet.